Home > Balance Sheet > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Deferred Tax Assets / Liabilities ₹4,972 Cr₹235 Cr₹101 Cr₹-142 Cr₹-300 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of TORRENT PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of TORRENT PHARMACEUTICALS is ₹4,972 Cr based on Mar2026 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2026₹4,972 Cr
Mar2025₹235 Cr
Mar2024₹101 Cr
Mar2023₹-142 Cr
Mar2022₹-300 Cr

How is Deferred Tax Assets / Liabilities of TORRENT PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2026 ₹4,972 Cr
2,019.53
Mar2025 ₹235 Cr
132.43
Mar2024 ₹101 Cr
Positive
Mar2023 ₹-142 Cr
Negative
Mar2022 ₹-300 Cr -

Compare Deferred Tax Assets / Liabilities of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹177,266.4 Cr -2% -6.1% 33% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics
MANKIND PHARMA ₹97,850.4 Cr -4.5% 2.7% -2.1% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-2%

-6.1%

33%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses